[Effect of NF-κB Inhibitor PDTC on Proliferation and Apoptosis of Acute Leukemia Cell HL-60]. 2020

Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
Department of Hematology, The First Affiliated Hospital of Hainan Medical University, Haikou 570100, Hainan Province, China.

OBJECTIVE To explore the effect of nuclear factor kappa-B (NF-κB) inhibitor pyrrolidine dithiocarbamate (PDTC) on the proliferation and apoptosis of acute leukemia cell HL-60. METHODS HL-60 cells were cultured with PDTC of 0, 25, 50, 100 μmol/L for 24, 48, 72 h. The inhibition rate of cell proliferation was detected by CCK-8 assay. Cell apoptosis was detected by Hoechst staining. Cell cycle was detected by flow cytometry. The expression of B-cell lymphoma-2 (BCL-2), BCL-2 associated X protein (BAX), cyclinD1, activated cysteinyl aspartate specific proteinase (cleaved caspase 3), cleaved caspase 8 and activation of NF-κB signal pathway related protein was detected by Western blot. RESULTS After the HL-60 cells were cultured with PDTC of 25, 50, 100 μmol/L for 24, 48, 72 h, the inhibition rate of cell proliferation increased with the enhancement of PDTC concentration at the same time point (r=0.924, P<0.01). At the same PDTC concentration, the inhibition rate of cell proliferation increased with prolonging of time (r=0.952, P<0.01). After HL-60 cell was cultured with PDTC of 25, 50, 100 μmol/L for 48 h, compared with control group, PDTC of 25, 50, 100 μmol/L increased the cell apoptotic rate, arrested cell cycle at G1 phase (P<0.01), the expression of BCL-2, cyclinD1 and p-NF-κB p65 was down-regulated(P<0.05), the expression of BAX, cleaved caspase 3, cleaved caspase 8 was up-regulated(P<0.01). PDTC of 50, 100 μmol/L down-regulated the expression of p-inhibitor of NF-κB (p-IκBα)(P<0.01). CONCLUSIONS PDTC can inhibit acute leukemia HL-60 cell proliferation and induce cell apoptosis.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013859 Thiocarbamates Carbamates in which the -CO- group has been replaced by a -CS- group. Thiocarbamate
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell

Related Publications

Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
December 2010, Zhongguo shi yan xue ye xue za zhi,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
December 2012, Eye science,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
March 2004, Acta pharmacologica Sinica,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
June 2013, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
December 2010, Zhongguo shi yan xue ye xue za zhi,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
January 1990, Archivum immunologiae et therapiae experimentalis,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
March 2008, International journal of hematology,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
December 2017, European review for medical and pharmacological sciences,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
June 2014, Zhongguo shi yan xue ye xue za zhi,
Shi Tao, and Shan-Qi Xu, and Ming-Xiu Jiao, and Yu Chen, and Cai-Bo Fu, and Min Hu
January 2016, Journal of cancer research and therapeutics,
Copied contents to your clipboard!